Sitagliptin 100 mg tablets,Sitagliptin 100 mg tablets
Sponsors
R.X. Manufacturing Co., Ltd., Thailand, Mylan Laboratories Limited.
Conditions
Healthy subjects
Bioequivalence (Sitagliptin) 100 mg
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Sitagliptin 100 mg Tablets relative to JanuviaTM (Sitagliptin) 100 mg Tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20220127006
Start: 2022-06-07Target: 26Updated: 2026-08-03
A Bioequivalence study of a randomization blinded, single dose, two- way crossover design with two-period, two-treatment and two-sequence of Sitagliptin tablets 100 mg relative to JANUVIA 100 mg in healthy Thai adult volunteers under fasting condition.
Active, not recruitingTCTR20220401003
Start: 2022-07-19Target: 36Updated: 2026-08-03